Key points from article :
90% of terminally ill patients treated went into remission.
Leukaemia patients’ own white blood cells extracted, modified and returned to body.
Genetically modified t-cells engineered to target chimeric antigen receptors.
Reprogrammed to recognise and destroy the patient’s tumour cells.
